Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.65 |
| ▸ | PKM | P14618 | 4/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.65 |
| ▸ | RAB9A | P51151 | 3/20 | 0.65 |
| ▸ | POLB | P06746 | 1/20 | 0.65 |
| ▸ | GAA | P10253 | 1/20 | 0.65 |
| ▸ | TP53 | P04637 | 3/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.58 |
| ▸ | TSHR | P16473 | 3/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | NPC1 | O15118 | 2/20 | 0.58 |
| ▸ | METAP2 | P50579 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5799814 | 0.87 | METAP2 (0.59) | MAPTSMN1; SMN2KDM4EPKMALDH1A1 | |
| SCHEMBL22481864 | 0.85 | MAPT (0.69) | MAPTSMN1; SMN2KDM4EPKMALDH1A1 | |
| SCHEMBL24704424 | 0.84 | KDM4E (0.60) | MAPTSMN1; SMN2KDM4EPKMALDH1A1 | |
| SCHEMBL24704131 | 0.84 | MAPT (0.53) | MAPTSMN1; SMN2KDM4EPKMALDH1A1 | |
| SCHEMBL31501268 | 0.84 | SMN1; SMN2 (0.52) | MAPTSMN1; SMN2KDM4EPKMALDH1A1 | |
| SCHEMBL31501264 | 0.84 | ACHE (0.57) | MAPTSMN1; SMN2KDM4EPKMALDH1A1 | |
| SCHEMBL18416146 | 0.79 | RAB9A (0.82) | MAPTSMN1; SMN2KDM4EPKMALDH1A1 | |
| SCHEMBL27404178 | 0.78 | KDM4E (0.50) | MAPTSMN1; SMN2KDM4EPKMALDH1A1 | |
| SCHEMBL31501263 | 0.78 | CYP1A2 (0.61) | MAPTSMN1; SMN2KDM4EPKMALDH1A1 | |
| SCHEMBL17595662 | 0.77 | ALDH1A1 (0.49) | MAPTSMN1; SMN2KDM4EPKMALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090274967-A1 | QUINOXALINE CONTAINING PHOTOCONDUCTORS | XEROX CORPORATION (US) | 2009-11-05 | — | — | US | claimed |
| US-12065541-B2 | Thermoplastic resin, optical film made therefrom, diol compound, diester compound | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-08-20 | — | — | US | disclosed |
| CN-113950500-B | Thermoplastic resin, optical film comprising the same, diol compound, and diester compound | 三菱化学株式会社 | 2023-11-03 | — | — | CN | disclosed |
| EP-3988599-B1 | THERMOPLASTIC RESIN, OPTICAL FILM MADE THEREFROM, DIOL COMPOUND, DIESTER COMPOUND | MITSUBISHI CHEM CORP (JP) | 2023-10-18 | — | — | EP | disclosed |
| US-20230265058-A1 | CARBOXYLIC ACID OR CARBOXYLIC ACID ESTER COMPOUND HAVING FUSED-RING STRUCTURE, METHOD FOR PRODUCING THE SAME, AND USE OF COMPOUND | FUJIFILM CORPORATION (JP) | 2023-08-24 | — | — | US | disclosed |
| US-20230265058-A1 | CARBOXYLIC ACID OR CARBOXYLIC ACID ESTER COMPOUND HAVING FUSED-RING STRUCTURE, METHOD FOR PRODUCING THE SAME, AND USE OF COMPOUND | FUJIFILM CORPORATION (JP) | 2023-08-24 | — | — | US | disclosed |
| US-20230183406-A1 | COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT, OPTICAL MEMBER, AND LENS | FUJIFILM CORPORATION (JP) | 2023-06-15 | — | — | US | disclosed |
| US-20230183406-A1 | COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT, OPTICAL MEMBER, AND LENS | FUJIFILM CORPORATION (JP) | 2023-06-15 | — | — | US | disclosed |
| EP-3988599-A1 | THERMOPLASTIC RESIN, OPTICAL FILM MADE THEREFROM, DIOL COMPOUND, DIESTER COMPOUND | Mitsubishi Chemical Corporation (JP) | 2022-04-27 | — | — | EP | disclosed |
| US-20220081510-A1 | THERMOPLASTIC RESIN, OPTICAL FILM MADE THEREFROM, DIOL COMPOUND, DIESTER COMPOUND | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-03-17 | — | — | US | disclosed |
| CN-113950500-A | Thermoplastic resin, optical film comprising the same, diol compound, and diester compound | 三菱化学株式会社 | 2022-01-18 | — | — | CN | disclosed |
| US-20160106743-A1 | TOPOISOMERASE II POISONS AND METHODS OF MAKING AND USING SAME | THE UNIVERSITY OF ROCHESTER (US) | 2016-04-21 | — | — | US | disclosed |
| US-8999522-B2 | 6H-indolo[2,3-b]quinoxaline derivatives and organic light emitting diode using the same | NATIONAL TSING HUA UNIVERSITY (TW) | 2015-04-07 | — | — | US | disclosed |
| US-20110303901-A1 | 6H-INDOLO[2,3-b]QUINOXALINE DERIVATIVES AND ORGANIC LIGHT EMITTING DIODE USING THE SAME | NATIONAL TSING HUA UNIVERSITY (TW) | 2011-12-15 | — | — | US | disclosed |
| US-20090274967-A1 | QUINOXALINE CONTAINING PHOTOCONDUCTORS | XEROX CORPORATION (US) | 2009-11-05 | — | — | US | disclosed |
| US-20090274967-A1 | QUINOXALINE CONTAINING PHOTOCONDUCTORS | XEROX CORPORATION (US) | 2009-11-05 | — | — | US | disclosed |
| US-20090274967-A1 | QUINOXALINE CONTAINING PHOTOCONDUCTORS | XEROX CORPORATION (US) | 2009-11-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220081510-A1 | THERMOPLASTIC RESIN, OPTICAL FILM MADE THEREFROM, DIOL COMPOUND, DIESTER COMPOUND | RTF1, RNF10, RAD51 | MAPT 1644/4885SMN1; SMN2 3641/4885KDM4E 2174/4885 |
| US-20230183406-A1 | COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT, OPTICAL MEMBER, AND LENS | POLR1A, RAD51, POLR2A | MAPT 419/4885SMN1; SMN2 587/4885KDM4E 2324/4885 |
| US-12065541-B2 | Thermoplastic resin, optical film made therefrom, diol compound, diester compound | RTF1, RNF31, RNF10 | MAPT 2085/4885SMN1; SMN2 3392/4885KDM4E 1758/4885 |
| US-20110303901-A1 | 6H-INDOLO[2,3-b]QUINOXALINE DERIVATIVES AND ORGANIC LIGHT EMITTING DIODE USING THE SAME | IDO1, IPO9, IDO2 | MAPT 2821/4885SMN1; SMN2 4750/4885KDM4E 2052/4885 |
| US-20230265058-A1 | CARBOXYLIC ACID OR CARBOXYLIC ACID ESTER COMPOUND HAVING FUSED-RING STRUCTURE, METHOD FOR PRODUCING THE SAME, AND USE OF COMPOUND | SPG11, HAT1, ASS1 | MAPT 1976/4885SMN1; SMN2 567/4885KDM4E 4186/4885 |
| US-20160106743-A1 | TOPOISOMERASE II POISONS AND METHODS OF MAKING AND USING SAME | TOP2A, TOP2B, TOP1 | MAPT 3723/4885SMN1; SMN2 1196/4885KDM4E 2782/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.